|Articles|April 12, 2021
Downstream Biologics Characterization: Stability, Formulations and Aggregation Studies using Octet®
Author(s)Sartorius
Aggregates can affect the efficacy and safety of biologics. Few biophysical tools offer a combination of structural and functional assessment. Octet® systems can detect aggregates while monitoring functional activity at the formulation stage of drug development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
2
How Mitigation and Maintenance Protect Against Future Risk
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
Navigating the Next Wave of Biopharma Manufacturing Innovation
5
